Tags

Type your tag names separated by a space and hit enter

Heterologous vaccine regimens against COVID-19.
Lancet. 2021 07 10; 398(10295):94-95.Lct

Authors+Show Affiliations

Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, 08007, Barcelona, Spain. Electronic address: tduarte@idiapjgol.org.Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Comment

Language

eng

PubMed ID

34181881

Citation

Duarte-Salles, Talita, and Daniel Prieto-Alhambra. "Heterologous Vaccine Regimens Against COVID-19." Lancet (London, England), vol. 398, no. 10295, 2021, pp. 94-95.
Duarte-Salles T, Prieto-Alhambra D. Heterologous vaccine regimens against COVID-19. Lancet. 2021;398(10295):94-95.
Duarte-Salles, T., & Prieto-Alhambra, D. (2021). Heterologous vaccine regimens against COVID-19. Lancet (London, England), 398(10295), 94-95. https://doi.org/10.1016/S0140-6736(21)01442-2
Duarte-Salles T, Prieto-Alhambra D. Heterologous Vaccine Regimens Against COVID-19. Lancet. 2021 07 10;398(10295):94-95. PubMed PMID: 34181881.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Heterologous vaccine regimens against COVID-19. AU - Duarte-Salles,Talita, AU - Prieto-Alhambra,Daniel, Y1 - 2021/06/25/ PY - 2021/06/16/received PY - 2021/06/18/accepted PY - 2021/6/29/pubmed PY - 2021/7/16/medline PY - 2021/6/28/entrez SP - 94 EP - 95 JF - Lancet (London, England) JO - Lancet VL - 398 IS - 10295 SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/34181881/Heterologous_vaccine_regimens_against_COVID-19. L2 - https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(21)01442-2 DB - PRIME DP - Unbound Medicine ER -